A Systematic Review on the Role of Adjunctive Corticosteroids in Herpes Simplex Virus Encephalitis: Is Timing Critical for Safety and Efficacy?

Raschilas F. , Wolff M. , Delatour F. Outcome of and prognostic factors for herpes simplex encephalitis in adult patients: results of a multicenter study. Clin Infect Dis 2002; 35: 254–260.

Hjalmarsson A. , Blomqvist P. , Sköldenberg B. Herpes simplex encephalitis in Sweden, 1990–2001 incidence, morbidity and mortality. Clin Infect Dis 2007; 45: 875–880.

Mailles A. , Stahl J.P. Infectious encephalitis in France in 2007: a national prospective study. Clin Infect Dis 2009; 49: 1838–1847.

Aurelius E. , Johansson B. , Sköldenberg B. , Forsgren M. Encephalitis in immunocompetent patients due to herpes simplex virus type 1 or 2 as determined by type-specific polymerase chain reaction and antibody assays of cerebrospinal fluid. J Med Virol 1993; 39: 179–186.

McGrath N. , Anderson N.E. , Croxson M.C. , Powell K.F. Herpes simplex encephalitis treated with acyclovir: diagnosis and long term outcome. J Neurol Neurosurg Psychiatry 1997; 63: 321–326.

Whitley R.J. Viral encephalitis. N Engl J Med 1990; 323: 242–250.

Gordon B. , Selnes O.A. , Hart J. Jr. , Hanley D.F. , Whitley R.J. Long-term cognitive sequelae of acyclovir-treated herpes simplex encephalitis. Arch Neurol 1990; 47: 646–647.

Tunkel A.R. , Glaser C.A. , Bloch K.C. The management of encephalitis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis 2008; 47: 303–327.

Solomon T. , Michael B.D. , Smith P.E. Management of suspected viral encephalitis in adults–Association of British Neurologists and British Infection Association National Guidelines. J Infect 2012; 64: 347–373.

Steiner I. , Budka H. , Chaudhuri A. Viral meningoencephalitis: a review of diagnostic methods and guidelines for management. Eur J Neurol 2010; 17: 999–e57.

Reading P.C. , Whitney P.G. , Barr D.P. NK cells contribute to the early clearance of HSV-1 from the lung but cannot control replication in the central nervous system following intranasal infection. Eur J Immunol 2006; 36: 897–905.

Theil D. , Derfuss T. , Paripovic I. Latent herpesvirus infection in human trigeminal ganglia causes chronic immune response. Am J Pathol 2003; 163: 2179–2184.

Blewitt R.W. , Abbott A.C. , Bird C.C. Mode of cell death induced in human lymphoid cells by high and low doses of glucocorticoid. Br J Cancer 1983; 47: 477–486.

Freeman M.L. , Sheridan B.S. , Bonneau R.H. , Hendricks R.L. Psychological stress compromises CD8⁺ T cell control of latent herpes simplex virus type 1 infections. J Immunol 2007; 179: 322–328.

Ashcraft K.A. , Hunzeker J. , Bonneau R.H. Psychological stress impairs the local CD8⁺ T cell response to mucosal HSV-1 infection and allows for increased pathogenicity via a glucocorticoid receptor-mediated mechanism. Psychoneuroendocrinology 2008; 33: 951–963.

Steiner I. Herpes simplex virus encephalitis: new infection or reactivation? Curr Opin Neurol 2011; 24: 268–274.

Whitley R.J. , Levin M. , Barton N. Infections caused by herpes simplex virus in the immunocompromised host: natural history and topical acyclovir therapy. J Infect Dis 1984; 150: 323–329.

Graber J.J. , Rosenblum M.K. , DeAngelis L.M. Herpes simplex encephalitis in patients with cancer. J Neurooncol 2011; 105: 415–421.

Jacobs D.H. Herpes simplex virus encephalitis following corticosteroids and cranial irradiation. Neurology 1999; 52: 1108–1109.

Silvano G. , Lazzari G. , Resta F. , Buccoliero G. , Pezzella G. , Pisconti S. A herpes simplex virus-1 fatal encephalitis following chemo-radiotherapy, steroids and prophylactic cranial irradiation in a small cell lung cancer patient. Lung Cancer 2007; 57: 243–246.

Lizarraga K.J. , Alexandre L.C. , Ramos-Estebanez C. , Merenda A. Are steroids a beneficial adjunctive therapy in the immunosuppressed patient with herpes simplex virus encephalitis? Case Rep Neurol 2013; 5: 52–55.

Lima G.K. , Zolini G.P. , Mansur D.S. Toll-like receptor (TLR) 2 and TLR9 expressed in trigeminal ganglia are critical to viral control during herpes simplex virus 1 infection. Am J Pathol 2010; 177: 2433–2445.

Wang J.P. , Bowen G.N. , Zhou S. Role of specific innate immune responses in herpes simplex virus infection of the central nervous system. J Virol 2012; 86: 2273–2281.

Lafaille F.G. , Pessach I.M. , Zhang S.Y. Impaired intrinsic immunity to HSV-1 in human iPSC-derived TLR3-deficient CNS cells. Nature 2012; 491: 769–773.

Casrouge A. , Zhang S.Y. , Eidenschenk C. Herpes simplex virus encephalitis in human UNC-93B deficiency. Science 2006; 314: 308–312.

Almawi W.Y. , Melemedjian O.K. Negative regulation of nuclear factor-kappaB activation and function by glucocorticoids. J Mol Endocrinol 2002; 28: 69–78.

Maiolini A. , Carlson R. , Tipold A. Toll-like receptors 4 and 9 are responsible for the maintenance of the inflammatory reaction in canine steroid-responsive meningitis-arteritis, a large animal model for neutrophilic meningitis. J Neuroinflammation 2012; 9: 226.

Harrell A.J. , Sydiskis R.H. The effect of dexamethasone on the replication of herpes simplex virus in human gingival fibroblast cultures. J Baltimore Coll Dent Surg 1982; 35: 9–13.

Dreyer L.L. , Sydiskis R.J. , Bashirelahi N. Effect of dexamethasone on herpes simplex virus replication in mouse neuroblastoma cells (NB41A3): receptor characteristics. J Clin Lab Anal 1989; 3: 236–243.

Thompson K.A. , Blessing W.W. , Wesselingh S.L. Herpes simplex replication and dissemination is not increased by corticosteroid treatment in a rat model of focal herpes encephalitis. J Neurovirol 2000; 6: 25–32.

Meyding-Lamadé U. , Seyfer S. , Haas J. Experimental herpes simplex virus encephalitis: inhibition of the expression of inducible nitric oxide synthase in mouse brain tissue. Neurosci Lett 2002; 318: 21–24.

Meyding-Lamadé U.K. , Oberlinner C. , Rau P.R. Experimental herpes simplex virus encephalitis: a combination therapy of acyclovir and glucocorticoids reduces long-term magnetic resonance imaging abnormalities. J Neurovirol 2003; 9: 118–125.

Baringer J.R. , Klassen T. , Grumm F. Experimental herpes simplex virus encephalitis. Effect of corticosteroids and pyrimidine nucleoside. Arch Neurol 1976; 33: 442–446.

Ben-Hur T. , Cialic R. , Itzik A. A novel permissive role for glucocorticoids in induction of febrile and behavioral signs of experimental herpes simplex virus encephalitis. Neuroscience 2001; 108: 119–127.

Meyding-Lamadé U. , Lamade W. , Kehm R. Herpes simplex virus encephalitis: chronic progressive cerebral MRI changes despite good clinical recovery and low viral load – an experimental mouse study. Eur J Neurol 1999; 6: 531–538.

Meyding-Lamadé U.K. , Lamade W.R. , Wildemann B.T. , Sartor K. , Hacke W. Herpes simplex virus encephalitis: chronic progressive cerebral magnetic resonance imaging abnormalities in patients despite good clinical recovery. Clin Infect Dis 1999; 28: 148–149.

Wildemann B. , Ehrhart K. , Storch-Hagenlocher B. Quantitation of herpes simplex virus type 1 DNA in cells of cerebrospinal fluid of patients with herpes simplex virus encephalitis. Neurology 1997; 48: 1341–1346.

Martínez-Torres F.J. , Wagner S. , Haas J. Increased presence of matrix metalloproteinases 2 and 9 in short- and long-term experimental herpes simplex virus encephalitis. Neurosci Lett 2004; 368: 274–278.

Sellner J. , Dvorak F. , Zhou Y. Acute and long-term alteration of chemokine mRNA expression after anti-viral and anti-inflammatory treatment in herpes simplex virus encephalitis. Neurosci Lett 2005; 374: 197–202.

de Gans J. , van de Beek D. European Dexamethasone in Adulthood Bacterial Meningitis Study Investigators. Dexamethasone in adults with bacterial meningitis. N Engl J Med 2002; 347: 1549–1556.

Thwaites G.E. , Nguyen D.B. , Nguyen H.D. Dexamethasone for the treatment of tuberculous meningitis in adolescents and adults. N Engl J Med 2004; 351: 1741–1751.

Wilhelmus K.R. , Gee L. , Hauck W.W. Herpetic eye disease study. A controlled trial of topical corticosteroids for herpes simplex stromal keratitis. Ophthalmology 1994; 101: 1883–1895.

Sergerie Y. , Boivin G. , Gosselin D. , Rivest S. Delayed but not early glucocorticoid treatment protects the host during experimental herpes simplex virus encephalitis in mice. J Infect Dis 2007; 195: 817–825.

Habel A.H. , Brown J.K. Dexamethasone in herpes-simplex encephalitis. Lancet 1972; 299: 695.

Upton A.R. , Foster J.B. , Barwick D.D. Dexamethasone treatment in herpes-simplex encephalitis. Lancet 1971; 297: 861.

Kamei S. , Sekizawa T. , Shiota H. Evaluation of combination therapy using acyclovir and corticosteroid in adult patients with herpes simplex virus encephalitis. J Neurol Neurosurg Psychiatry 2005; 76: 1544–1549.

Nakano A. , Yamasaki R. , Miyazaki S. , Horiuchi N. , Kunishige M. , Mitsui T. Beneficial effect of steroid pulse therapy on acute viral encephalitis. Eur Neurol 2003; 50: 225–229.

Musallam B. , Matoth I. , Wolf D.G. , Engelhard D. , Averbuch D. Steroids for deteriorating herpes simplex virus encephalitis. Pediatr Neurol 2007; 37: 229–232.

Mesker A.J. , Bon G.G. , de Gans J. , de Kruijk J.R. Case report: a pregnant woman with herpes simplex encephalitis successfully treated with dexamethasone. Eur J Obstet Gynecol Reprod Biol 2011; 154: 231–232.

Martinez-Torres F. , Menon S. , Pritsch M. Protocol for German trial of Acyclovir and Corticosteroids in Herpes-simplex-virus-encephalitis (GACHE): a multicenter, multinational, randomized, double-blind, placebo-controlled German, Austrian and Dutch trial [ISRCTN45122933]. BMC Neurol 2008; 8: 40.

Carr D.J. Increased levels of IFN-gamma in the trigeminal ganglion correlate with protection against HSV-1-induced encephalitis following subcutaneous administration with androstenediol. J Neuroimmunol 1998; 89: 160–167.

Hasson J. , Weidenfeld J. , Mizrachi-Kol R. , Ben-Hur T. , Ovadia H. The effect of herpes simplex virus-1 on nitric oxide synthase in the rat brain: the role of glucocorticoids. Neuroimmunomodulation 2011; 18: 111–116.

Fujii S. , Akaike T. , Maeda H. Role of nitric oxide in pathogenesis of herpes virus encephalitis in rats. Virology 1999; 256: 203–212.

Benencia F. , Courreges M.C. , Gamba G. , Cavalieri H. , Massouh E.J. Effect of aminoguanidine, a nitric oxide synthase inhibitor, on ocular infection with herpes simplex virus in Balb/c mice. Invest Ophthalmol Vis Sci 2001; 42: 1277–1284.

Joyce D.A. , Steer J.H. , Abraham L.J. Glucocorticoid modulation of human monocyte/macrophage function: control of TNF-alpha secretion. Inflamm Res 1997; 46: 447–451.

Schmidt A. , Bunjes D. , Friedrich J. , Koenig W. , Eggeling T. , Hombach V. Neurological outcome after severe herpes simplex encephalitis treated with acyclovir and beta-interferon. Time course of intracranial pressure. Klin Wochenschr 1990; 68: 286–289.

Boivin N. , Menasria R. , Piret J. , Boivin G. Modulation of TLR9 response in a mouse model of herpes simplex virus encephalitis. Antiviral Res 2012; 96: 414–421.

Kamei S. , Taira N. , Ishihara M. Prognostic value of cerebrospinal fluid cytokine changes in herpes simplex virus encephalitis. Cytokine 2009; 46: 187–193.